Mounting evidence suggests that dietary caffeine intake may exert some beneficial effects in reducing dementia risk and possibly Alzheimer’s disease, and may be a viable therapeutic approach. Clinical studies also suggest that caffeine is a cognitive normalizer and not a cognitive enhancer. Moreover, some clinical studies suggest the neuroprotective effect of caffeine might be confounded by gender.
Research
DRNI Members Research is a list of ongoing and completed research carried out by DRNI members.
You can search via project type, disease, or Principal Investigator/Researcher name.